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To	the	Editor:
In	the	Clinical	Communication,	Dion	et	al1	reported	that	in	patients	with	severe	primary	antibody	deficiency	(PAD),	Campylobacter	infection	is	a	major	cause	(6.5%)	of	chronic	or	recurrent	diarrhea.	Moreover,
by	a	molecular	study	performed	in	a	subset	of	18	strains	from	5	patients	with	recurrent	infections,	they	demonstrated	that	all	strains	were	different,	even	when	the	episodes	occurred	closely	over	time.	Thus,	the
authors	hypothesized	that	reinfection	would	be	more	likely	than	persistent	colonization,	although	colonization	with	multiple	strains	cannot	be	excluded.
In	a	previous	study,2	our	group	showed	that	Campylobacter	coli	(C.	coli)	(6.7%)	was	the	first	cause	of	diarrhea	in	patients	with	symptomatic	PAD	with	a	positive	stool	culture,	followed	by	Campylobacter	jejuni	(C.
jejuni)	(3.9%).	Moreover,	C.	coli	was	also	the	most	frequent	isolate	(5%)	in	patients	with	asymptomatic	PAD,	followed	by	C.	jejuni	(1.2%),	whereas	in	immunocompetent	individuals,	C.	jejuni	is	one	of	the	most	prevalent
etiologic	agents	of	gastroenteritis	and	C.	coli	has	a	low	prevalence	in	diarrheal	disease.3,4
Differently	from	the	French	data,	we	showed	that	the	same	C.	coli	strain	has	been	isolated	for	more	than	10	years	in	an	asymptomatic	patient	with	XLA.2	As	previously	shown,5	after	this	long-lasting	silent
infection,	the	same	intestinal	strain	caused	recurrent	episodes	of	sepsis	and	leg	cellulitis,	without	changing	its	molecular	pattern.	The	same	shift	from	an	asymptomatic	colonization	to	a	life-threatening	disease	was
observed	in	a	patient	with	a	Good's	syndrome.	All	C.	coli	isolates,	including	the	strains	isolated	from	blood,	stool,	and	skin	lesion	at	the	time	of	the	sepsis	and	the	stool	strains	isolated	years	before—at	the	time	of	the
asymptomatic	carriage—showed	a	100%	genetic	homology	as	determined	by	pulsed	field	gel	electrophoresis,	amplified	fragment	length	polymorphism,	flaA-restricted	fragment	length	polymorphism,	and	multilocus
sequence	typing.
In	both	patients,	all	antibiotic	treatments	were	allowed	to	control	the	infection	at	the	time	of	recurrent	sepsis	and	only	after	a	long	course	of	oral	treatment	with	bacitracin/neomycin	stool	cultures	became
persistently	negative	and	there	was	no	disease	recurrence.
In	summary,	in	our	patients,	all	C.	coli	isolates	were	genetically	identical,	suggesting	a	long-lasting	latent	infection	and	not	a	reinfection	nor	colonization	with	different	strains.1	Differently	from	Dion	et	al,1	we
hypothesized	that	inability	to	mount	a	specific	immune	response	would	account	for	colonization	and	infection	and	for	the	genetic	stability	of	C.	coli.	As	we	have	previously	suggested,1	periodic	stool	cultures	with	highly
sensitive	techniques	should	be	performed	in	PAD.
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